[{"NetIncomeLoss_2_Q2_USD":-224076000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"MarketableSecuritiesCurrent_0_Q2_USD":350614000.0,"EquitySecuritiesFvNiGainLoss_2_Q2_USD":-3343000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":102.07,"DepreciationAndAmortization_2_Q2_USD":9430000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":57987000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":60384000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_0_Q2_USD":0.0,"CommitmentsAndContingencies_0_Q2_USD":null,"RestrictedCashCurrent_0_Q2_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q2_USD":106.9,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-2400000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q2_USD":332000000.0,"EquitySecuritiesFvNiCost_0_Q2_USD":20017000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_2_Q2_USD":2549000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":493854000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_2_Q2_USD":135.1,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":1306000.0,"InterestIncomeExpenseNonoperatingNet_2_Q2_USD":8294000.0,"InterestIncomeExpenseNonoperatingNet_1_Q2_USD":2939000.0,"AssetsCurrent_0_Q2_USD":1613445000.0,"OtherNoncashIncomeExpense_2_Q2_USD":1841000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_2_Q2_USD":101421000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":141876000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":68628000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":2579000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":1554000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":8382000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":347000.0,"EquitySecuritiesFvNi_0_Q2_USD":9527000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":541536000.0,"CommonStockSharesIssued_0_Q2_shares":66196000.0,"Liabilities_0_Q2_USD":425759000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":1198768000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":310431000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":156308000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":106.9,"DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_0_Q2_USD":5000.0,"InvestmentsAndCash_0_Q2_USD":1600000000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_2_Q2_USD":580875000.0,"PrepaidExpenseCurrent_0_Q2_USD":39358000.0,"ProceedsFromStockPlans_2_Q2_USD":1100000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-2896000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":1551000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":104000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":10000.0,"CommonStockValue_0_Q2_USD":662000.0,"Revenues_2_Q2_USD":220753000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":174564000.0,"Revenues_1_Q2_USD":198890000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_0_Q2_USD":10498000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_2_Q2_shares":296000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":544085000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_0_Q2_USD":0.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_2_Q2_USD":-4763000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1_Q2_USD":-1655000.0,"CostsAndExpenses_2_Q2_USD":450123000.0,"CostsAndExpenses_1_Q2_USD":224835000.0,"DebtSecuritiesAvailableForSaleRealizedGainLoss_2_Q2_USD":0.0,"AccruedLiabilitiesAndOtherLiabilities_0_Q2_USD":135612000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-224583000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-21066000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-14042000.0,"OtherAssetsNoncurrent_0_Q2_USD":74783000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q2_USD":0.0,"Assets_0_Q2_USD":2107790000.0,"ShareBasedCompensation_2_Q2_USD":84822000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":189464000.0,"CommonStockSharesOutstanding_0_Q2_shares":66196000.0,"RestrictedCashNoncurrent_0_Q2_USD":54502000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q2_shares":6466000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":43802000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_Q2_USD":-507000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":399000.0,"Goodwill_0_Q2_USD":13128000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-223972000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-21455000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":40781000.0,"RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_2_Q2_USD":111976000.0,"RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_1_Q2_USD":109674000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-166378000.0,"ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_2_Q2_USD":29878000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":871561000.0,"MarketableSecuritiesNoncurrent_0_Q2_USD":49411000.0,"AccountsPayableCurrent_0_Q2_USD":26181000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":1253270000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":30657000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":12183000.0,"AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_1_Q2_USD":33465000.0,"AdditionalPaidInCapital_0_Q2_USD":4189697000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":27000.0,"InterestReceivable_0_Q2_USD":1700000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPosition_0_Q2_USD":10498000.0,"NumberOfOperatingSegments_2_Q2_segment":1.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":1257000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":155376000.0,"NetIncomeLoss_1_Q2_USD":-21465000.0,"LiabilitiesCurrent_0_Q2_USD":197181000.0,"MarketableSecurities_0_Q2_USD":400025000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-2505928000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":3442000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.01,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":541536000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.01,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":13813000.0,"OtherComprehensiveIncomeLossTax_2_Q2_USD":100000.0,"OtherComprehensiveIncomeLossTax_1_Q2_USD":100000.0,"CommonStockSharesAuthorized_0_Q2_shares":125000000.0,"OperatingIncomeLoss_2_Q2_USD":-229370000.0,"OperatingIncomeLoss_1_Q2_USD":-25945000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0_Q2_shares":2400000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":3915000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":72.5,"PreferredStockValue_0_Q2_USD":0.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":40.91,"LiabilitiesAndStockholdersEquity_0_Q2_USD":2107790000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":39018000.0,"PreferredStockSharesAuthorized_0_Q2_shares":5000000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":6466000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":15478000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q2_USD":25762000.0,"StockholdersEquity_0_Q2_USD":1682031000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":4335000.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.36,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":11412000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-3.86,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2_Q2_USD":-14025000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":20955000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_0_Q2_USD":5000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":199178000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":48529000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":84822000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":14663000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":1847000.0,"Ticker":"BLUE","CIK":"1293971","name":"BLUEBIRD BIO, INC.","OfficialName":"bluebird bio Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"2","uom":"USD","footnote":"nan","Market Cap":"301448421.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20200805"}]